ReviewCurrent pain and headache reports2025
Peripheral Nerve Stimulation for Low Back Pain: A Review of the Recent Literature.
Review in Current pain and headache reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis article aims to evaluate and summarize the current literature surrounding peripheral nerve stimulation (PNS) as a management modality for chronic axial low back pain (CLBP). CLBP physiology as well as delivery of PNS and mechanisms of analgesia will be reviewed. Finally, we will evaluate the two current on-market PNS devices (SPRINT and ReActiv8) and the recent literature on both devices. RECENT
findingsWhile CLBP can be difficult to treat, recent literature demonstrates that PNS reduces pain scores and disability. The literature on PNS and the currently available devices (SPRINT and ReActiv8) is sparse, predominately comprised of case studies with limited randomized control trials. CLBP is one of the most common pain complaints and can be difficult to treat. PNS is emerging as a new treatment modality in the management of CLBP and shows promise in terms of reduction of pain and function. More research is necessary on PNS and the current principal devices available to evaluate its long-term impact on CLPB and how it can supplement or even replace current treatment modalities.
Indexed as
Identifiers
41348377What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.